获得性血栓性血小板减少性紫癜，可能与阿斯利康-牛津新冠疫苗有关。
Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine.
作者信息
Al-Ahmad Mona, Al-Rasheed Mona, Shalaby Neveen Abo Bakr
机构信息
Microbiology Department Faculty of Medicine Kuwait University Kuwait Kuwait.
Al Rashed Allergy Centre Ministry of Health Kuwait.
出版信息
EJHaem. 2021 May 18;2(3):534-536. doi: 10.1002/jha2.219. eCollection 2021 Aug.
Abstract
Acquired thrombotic thrombocytopenic purpura is characterized by the microvascular aggregation of platelets and microangiopathic hemolytic anemia causing ischemia of multiple organs including the brain mainly and less likely the kidney and the heart. The disease is caused by severe reduction in the activity of ADAMTS 13 due to presence of inhibitory antibodies.
摘要
获得性血栓性血小板减少性紫癜的特征是血小板在微血管聚集以及微血管病性溶血性贫血，导致包括脑在内的多个器官缺血，主要是脑，肾脏和心脏受累的可能性较小。该疾病是由于存在抑制性抗体导致ADAMTS 13活性严重降低所致。
相似文献
1
Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine.获得性血栓性血小板减少性紫癜，可能与阿斯利康-牛津新冠疫苗有关。
EJHaem. 2021 May 18;2(3):534-536. doi: 10.1002/jha2.219. eCollection 2021 Aug.
2
Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review.灭活新冠疫苗接种后获得性血栓性血小板减少性紫癜：两例报告及文献综述
Vaccines (Basel). 2022 Jun 24;10(7):1012. doi: 10.3390/vaccines10071012.
3
Thrombotic thrombocytopenic purpura following ChAdOx1 nCov-19 vaccination: A case report.ChAdOx1 nCov-19疫苗接种后发生血栓性血小板减少性紫癜：一例报告
IDCases. 2023 May 8;32:e01795. doi: 10.1016/j.idcr.2023.e01795. eCollection 2023.
4
Thrombotic thrombocytopenic purpura as a rare cause of anemia with thrombocytopenia in childhood: report of 2 cases.血栓性血小板减少性紫癜作为儿童期贫血伴血小板减少的罕见病因：2例报告
Turk J Pediatr. 2019;61(3):418-423. doi: 10.24953/turkjped.2019.03.015.
5
Acquired thrombotic thrombocytopenic purpura after AstraZeneca vaccine: A case report.阿斯利康疫苗接种后获得性血栓性血小板减少性紫癜：一例报告。
Caspian J Intern Med. 2022;13(Suppl 3):299-302. doi: 10.22088/cjim.13.0.299.
6
First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.首例接种 SARS-CoV-2 疫苗后发生的血栓性血小板减少性紫癜 - 病例报告。
BMC Nephrol. 2021 Dec 11;22(1):411. doi: 10.1186/s12882-021-02616-3.
7
Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.血栓性血小板减少性紫癜和其他血栓性微血管病性溶血性贫血：诊断和分类。
Autoimmun Rev. 2014 Apr-May;13(4-5):584-6. doi: 10.1016/j.autrev.2014.01.004. Epub 2014 Jan 11.
8
Analysis of clinical and laboratory characteristics in 42 patients with thrombotic thrombocytopenic purpura from a single center in China.中国某单中心42例血栓性血小板减少性紫癜患者的临床及实验室特征分析。
Transfus Apher Sci. 2013 Dec;49(3):447-52. doi: 10.1016/j.transci.2013.07.026. Epub 2013 Aug 7.
9
Thrombotic thrombocytopenic purpura presenting with pathologic fracture: a case report.以病理性骨折为表现的血栓性血小板减少性紫癜：一例报告
Transfus Apher Sci. 2014 Aug;51(1):73-6. doi: 10.1016/j.transci.2014.05.003. Epub 2014 Jul 28.
10
Thrombotic thrombocytopenic purpura associated with pesticides: A report of 4 cases and literature review.农药相关性血栓性血小板减少性紫癜：4例报告并文献复习
Transfus Apher Sci. 2020 Apr;59(2):102694. doi: 10.1016/j.transci.2019.102694. Epub 2019 Dec 13.
引用本文的文献
1
A Systematic Review of Vascular Injuries: A Review of Petechiae, Purpura, and Ecchymosis in Critical Situations Following COVID-19 Vaccination.血管损伤的系统评价：新冠疫苗接种后危急情况下瘀点、紫癜和瘀斑的综述
Health Sci Rep. 2025 Mar 12;8(3):e70503. doi: 10.1002/hsr2.70503. eCollection 2025 Mar.
2
Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac.与科兴中维新冠疫苗相关的获得性免疫性血栓性血小板减少性紫癜（TTP）。
Front Med. 2024 Aug;18(4):744-751. doi: 10.1007/s11684-023-1054-2. Epub 2024 Jul 3.
3
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.2019冠状病毒病疫苗诱导的皮肤并发症的管理：一项全面的文献综述。
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.
4
Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura (TTP) With Caplacizumab: A Case Report.卡泊单抗成功治疗难治性血栓性血小板减少性紫癜（TTP）：一例报告
Cureus. 2023 Jul 25;15(7):e42423. doi: 10.7759/cureus.42423. eCollection 2023 Jul.
5
Recurrence of Thrombotic Thrombocytopenic Purpura After Vaccination with mRNA-1273 COVID-19 vaccine.接种mRNA-1273新冠疫苗后血栓性血小板减少性紫癜复发
J Community Hosp Intern Med Perspect. 2022 Jul 4;12(4):80-84. doi: 10.55729/2000-9666.1073. eCollection 2022.
6
New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review.新型冠状病毒肺炎疫苗接种后新发和复发肝病：系统评价。
BMC Gastroenterol. 2022 Oct 13;22(1):433. doi: 10.1186/s12876-022-02507-3.
7
SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体、当前的新冠疫苗及其对2019冠状病毒病（COVID-19）的治疗意义
Vaccines (Basel). 2022 Sep 16;10(9):1538. doi: 10.3390/vaccines10091538.
8
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
9
Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review.灭活新冠疫苗接种后获得性血栓性血小板减少性紫癜：两例报告及文献综述
Vaccines (Basel). 2022 Jun 24;10(7):1012. doi: 10.3390/vaccines10071012.
10
Acquired thrombotic thrombocytopenic purpura after AstraZeneca vaccine: A case report.阿斯利康疫苗接种后获得性血栓性血小板减少性紫癜：一例报告。
Caspian J Intern Med. 2022;13(Suppl 3):299-302. doi: 10.22088/cjim.13.0.299.
本文引用的文献
1
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura.国际血栓与止血学会（ISTH）血栓性血小板减少性紫癜治疗指南。
J Thromb Haemost. 2020 Oct;18(10):2496-2502. doi: 10.1111/jth.15010. Epub 2020 Sep 11.
2
Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015.血栓性血小板减少性紫癜：1995年至2015年的诊断标准、临床特征及长期预后
Blood Adv. 2017 Apr 6;1(10):590-600. doi: 10.1182/bloodadvances.2017005124. eCollection 2017 Apr 11.
3
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.用于快速评估血栓性微血管病成人患者的PLASMIC评分的推导与外部验证：一项队列研究
Lancet Haematol. 2017 Apr;4(4):e157-e164. doi: 10.1016/S2352-3026(17)30026-1. Epub 2017 Mar 2.
4
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.伴有严重ADAMTS13缺乏的成人期血栓性微血管病（血栓性血小板减少性紫癜）的流行病学和病理生理学：法国全国血栓性微血管病登记处的横断面分析
Lancet Haematol. 2016 May;3(5):e237-45. doi: 10.1016/S2352-3026(16)30018-7. Epub 2016 Apr 16.
5
Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.心肌肌钙蛋白 I 有助于诊断，可预测获得性血栓性血小板减少性紫癜的早期死亡和难治性。法国血栓性微血管病参考中心的经验。
J Thromb Haemost. 2015 Feb;13(2):293-302. doi: 10.1111/jth.12790. Epub 2014 Dec 18.
6
Rabies vaccine-associated thrombotic thrombocytopenic purpura.狂犬病疫苗相关血栓性血小板减少性紫癜
Transfus Med. 2014 Dec;24(6):428-9. doi: 10.1111/tme.12160. Epub 2014 Nov 10.
7
Acute thrombotic thrombocytopenic purpura after pneumococcal vaccination.肺炎球菌疫苗接种后发生急性血栓性血小板减少性紫癜
Blood Coagul Fibrinolysis. 2014 Jul;25(5):512-4. doi: 10.1097/MBC.0000000000000058.
8
Pulmonary involvement in patients with thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜患者的肺部受累。
Eur J Haematol. 2014 Feb;92(2):156-63. doi: 10.1111/ejh.12222. Epub 2013 Nov 26.
9
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features.与严重获得性 ADAMTS13 缺乏相关的血栓性血小板减少性紫癜的儿童和成人：发病率、人口统计学和临床特征比较。
Pediatr Blood Cancer. 2013 Oct;60(10):1676-82. doi: 10.1002/pbc.24612. Epub 2013 Jun 1.
10
Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience.血栓性血小板减少性紫癜中获得性 ADAMTS13 缺乏症的临床特征：韩国 TTP 登记处的经验。
Int J Hematol. 2011 Feb;93(2):163-169. doi: 10.1007/s12185-011-0771-5. Epub 2011 Feb 3.
Zotero 插件